![](/img/cover-not-exists.png)
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non–ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial
David A. Morrow, Benjamin M. Scirica, Ewa Karwatowska-Prokopczuk, Allan Skene, Carolyn H. McCabe, Eugene BraunwaldVolume:
151
Year:
2006
Language:
english
Pages:
65535
DOI:
10.1016/j.ahj.2006.01.004
File:
PDF, 203 KB
english, 2006